{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:29:55Z","timestamp":1791318595524,"version":"4.3.1"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 DK069629"],"award-info":[{"award-number":["R01 DK069629"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 GM044931"],"award-info":[{"award-number":["R01 GM044931"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.cca.2013.07.013","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T09:05:53Z","timestamp":1374656753000},"page":"64-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":370,"special_numbering":"C","title":["Review: Glycation of human serum albumin"],"prefix":"10.1016","volume":"425","author":[{"given":"Jeanethe","family":"Anguizola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar S.","family":"Barnaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.S.","family":"Hoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Wa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"DeBolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Koke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.07.013_bb0005","series-title":"International Diabetes Federation diabetes atlas","year":"2011"},{"key":"10.1016\/j.cca.2013.07.013_bb0010","series-title":"National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2011","year":"2011"},{"key":"10.1016\/j.cca.2013.07.013_bb0015","series-title":"Lehninger principles of biochemistry","year":"2005"},{"key":"10.1016\/j.cca.2013.07.013_bb0020","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ejheart.2007.09.009","article-title":"Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications","volume":"9","author":"Hartog","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cca.2013.07.013_bb0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ehj.2003.12.007","article-title":"The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm","volume":"25","author":"Olijhoeka","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2013.07.013_bb0030","doi-asserted-by":"crossref","first-page":"912","DOI":"10.7326\/0003-4819-121-12-199412150-00002","article-title":"End-stage renal disease attributable to diabetes mellitus","volume":"121","author":"Perneger","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2013.07.013_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s005920050066","article-title":"Temporal association between lens protein glycation and cataract development in diabetic rats","volume":"34","author":"Turk","year":"1997","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.cca.2013.07.013_bb0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2337\/diacare.12.1.24","article-title":"Lower-extremity amputation in people with diabetes. Epidemiology and prevention","volume":"12","author":"Bild","year":"1989","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2013.07.013_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/0264-6021:3440109","article-title":"Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose","volume":"344","author":"Thornalley","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.cca.2013.07.013_bb0050","first-page":"66","article-title":"Action des acides amines sur les sucres: formation des melanoidines par voie methodique","volume":"154","author":"Maillard","year":"1912","journal-title":"C R Acad Sci"},{"key":"10.1016\/j.cca.2013.07.013_bb0055","series-title":"The Maillard reaction","author":"Nursten","year":"2005"},{"key":"10.1016\/j.cca.2013.07.013_bb0060","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/jms.842","article-title":"Mass spectrometric study of in vivo production of advanced glycation end-products\/peptides","volume":"40","author":"Lapolla","year":"2005","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.cca.2013.07.013_bb0065","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mas.20090","article-title":"The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: an update","volume":"25","author":"Lapolla","year":"2006","journal-title":"Mass Spectrom Rev"},{"key":"10.1016\/j.cca.2013.07.013_bb0070","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/pr800858h","article-title":"A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease","volume":"8","author":"Zhang","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.cca.2013.07.013_bb0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0076-6879(84)06010-9","article-title":"Nonenzymatic glucosylation of lysine residues in albumin","volume":"106","author":"Baynes","year":"1984","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.cca.2013.07.013_bb0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0174-173X(82)80042-3","article-title":"Nonenzymatic glycosylation of collagen and other proteins: relationship to development of diabetic complications","volume":"2","author":"Perejda","year":"1982","journal-title":"Coll Relat Res"},{"key":"10.1016\/j.cca.2013.07.013_bb0085","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0003-9861(83)90161-3","article-title":"The nonenzymatic glycosylation of collagen","volume":"221","author":"Rogozinski","year":"1983","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.cca.2013.07.013_bb0090","first-page":"173","article-title":"Nonenzymatic glycosylation of proteins in diabetes mellitus","volume":"1","author":"Jones","year":"1984","journal-title":"Recent Adv Diabetes"},{"key":"10.1016\/j.cca.2013.07.013_bb0095","series-title":"All about albumin: biochemistry, genetics, and medical applications","author":"Peters","year":"1996"},{"key":"10.1016\/j.cca.2013.07.013_bb0100","series-title":"Textbook of clinical chemistry","year":"1986"},{"key":"10.1016\/j.cca.2013.07.013_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/med.10039","article-title":"In silico prediction of drug-binding strengths to human serum albumin","volume":"23","author":"Colmenarejo","year":"2003","journal-title":"Med Res Rev"},{"key":"10.1016\/j.cca.2013.07.013_bb0110","doi-asserted-by":"crossref","first-page":"29303","DOI":"10.1074\/jbc.274.41.29303","article-title":"The three recombinant domains of human serum albumin","volume":"274","author":"Dockal","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.cca.2013.07.013_bb0120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2133\/dmpk.20.309","article-title":"A molecular functional study on the interactions of drugs with plasma proteins","volume":"20","author":"Otagiri","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.cca.2013.07.013_bb0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/la010964j","article-title":"The role of specific binding in human serum albumin adsorption to self-assembled monolayers","volume":"18","author":"Choi","year":"2002","journal-title":"Langmuir"},{"key":"10.1016\/j.cca.2013.07.013_bb0130","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1016\/S0021-9258(17)43168-1","article-title":"Nonenzymatic glycosylation of human serum albumin alters its conformation and function","volume":"259","author":"Shaklai","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0135","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/1869","article-title":"Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites","volume":"5","author":"Curry","year":"1998","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.cca.2013.07.013_bb0140","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/(SICI)1099-081X(199712)18:9<791::AID-BDD66>3.0.CO;2-1","article-title":"Effects of glycosylation of hypoglycemic drug binding to serum albumin","volume":"18","author":"Koyama","year":"1997","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.cca.2013.07.013_bb0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/chir.20301","article-title":"Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism","volume":"18","author":"Ascoli","year":"2006","journal-title":"Chirality"},{"key":"10.1016\/j.cca.2013.07.013_bb0150","doi-asserted-by":"crossref","first-page":"17958","DOI":"10.1073\/pnas.0506440102","article-title":"Locating high-affinity fatty acid-binding sites on albumin by X-ray crystallography and NMR spectroscopy","volume":"102","author":"Simard","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2013.07.013_bb0155","first-page":"824","article-title":"Characterization of two specific drug binding sites on human serum albumin","volume":"11","author":"Sudlow","year":"1975","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.cca.2013.07.013_bb0160","first-page":"1052","article-title":"Further characterization of specific drug binding sites on human serum albumin","volume":"12","author":"Sudlow","year":"1976","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.cca.2013.07.013_bb0165","first-page":"91","article-title":"Characterization of the binding of digitoxin and acetyldigitoxin to human serum albumin by high-performance affinity chromatography","volume":"725","author":"Sengupta","year":"1999","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.cca.2013.07.013_bb0170","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1021\/ac980734i","article-title":"Studies of protein binding to non-polar solutes by using zonal elution and high-performance affinity chromatography: interactions of cis- and trans-clomiphene with human serum albumin in the presence of \u03b2-cyclodextrin","volume":"70","author":"Hage","year":"1998","journal-title":"Anal Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0175","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/ac00093a043","article-title":"Chiral separation mechanisms in protein-based HPLC columns. I. Thermodynamic studies of R- and S-warfarin binding to immobilized human serum albumin","volume":"66","author":"Loun","year":"1994","journal-title":"Anal Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0180","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0021-9673(93)83383-4","article-title":"Characterization of the binding and chiral separation of d- and l-tryptophan on a high-performance immobilized human serum albumin column","volume":"645","author":"Yang","year":"1993","journal-title":"J Chromatogr"},{"key":"10.1016\/j.cca.2013.07.013_bb0185","first-page":"851","article-title":"Measurement of circulating glycated proteins to monitor intermediate-term changes in glycaemic control","volume":"30","author":"Cohen","year":"1992","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.cca.2013.07.013_bb0190","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1177\/193229680800200620","article-title":"A review of glycated albumin as an intermediate glycation index for controlling diabetes","volume":"2","author":"Roohk","year":"2008","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.cca.2013.07.013_bb0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.diabet.2011.11.002","article-title":"Structural modifications of human albumin in diabetes","volume":"38","author":"Guerin-Dubourg","year":"2012","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.cca.2013.07.013_bb0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/clinchem\/47.2.153","article-title":"Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin","volume":"47","author":"Bry","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0205","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.cca.2012.04.025","article-title":"Glycated albumin in diabetic patients with chronic kidney disease","volume":"413","author":"Zheng","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.07.013_bb0210","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1373\/clinchem.2012.196139","article-title":"Comparing multiple measures of glycemia: how to transition from biomarker to diagnostic test?","volume":"58","author":"Cohen","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00592-010-0242-0","article-title":"Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetes patients","volume":"48","author":"Lee","year":"2011","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.cca.2013.07.013_bb0220","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.2215\/CJN.04210511","article-title":"Assessment of glycemic control in dialysis patients: glycosylated hemoglobin or glycated albumin?","volume":"6","author":"Mehrotra","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cca.2013.07.013_bb0225","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/clinchem\/33.12.2153","article-title":"Fructosamine: structure, analysis, and clinical usefulness","volume":"33","author":"Armbruster","year":"1987","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0009-8981(92)90133-B","article-title":"Measurement of glycated albumin by the nitroblue tetrazolium colorimetric method","volume":"212","author":"Mashiba","year":"1992","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.07.013_bb0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1248\/bpb.16.195","article-title":"A novel colorimetric method for determination of glycated protein based on 2-keto-glucose release with hydrazine","volume":"16","author":"Kobayashi","year":"1993","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.cca.2013.07.013_bb0240","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/clinchem\/40.10.1950","article-title":"Chemistry of the fructosamine assay: d-glucosone is the product of oxidation of Amadori compounds","volume":"40","author":"Baker","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0245","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/clinchem\/30.3.446","article-title":"Quantification of nonenzymically glycated albumin and total serum protein by affinity chromatography","volume":"30","author":"Yatscoff","year":"1984","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0250","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1142\/9789812831620_0003","article-title":"Glycated albumin analyzer","volume":"1","author":"Uchida","year":"1996","journal-title":"Methods Chromatogr"},{"key":"10.1016\/j.cca.2013.07.013_bb0255","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1073\/pnas.89.6.2218","article-title":"Increased permeability across the blood\u2013nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy","volume":"89","author":"Poduslo","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2013.07.013_bb0260","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0021-9673(92)80120-J","article-title":"High-performance affinity chromatography system for the rapid, efficient assay of glycated albumin","volume":"597","author":"Yasukawa","year":"1992","journal-title":"J Chromatogr"},{"key":"10.1016\/j.cca.2013.07.013_bb0265","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jpba.2012.01.004","article-title":"Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments","volume":"69","author":"Hage","year":"2012","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cca.2013.07.013_bb0270","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/clinchem\/45.5.593","article-title":"Affinity chromatography: a review of clinical applications","volume":"45","author":"Hage","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/152091599317585","article-title":"Measuring glycated proteins: clinical and methodological aspects","volume":"1","author":"Cohen","year":"1999","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.cca.2013.07.013_bb0280","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0022-1759(89)90275-5","article-title":"Measurement of plasma glycoalbumin levels with a monoclonal antibody based ELISA","volume":"122","author":"Cohen","year":"1989","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.cca.2013.07.013_bb0285","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/clinchem\/44.2.256","article-title":"Determination of glycated albumin by enzyme-linked boronate immunoassay (ELBIA)","volume":"44","author":"Ikeda","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0290","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.clinbiochem.2007.08.001","article-title":"Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma","volume":"40","author":"Paroni","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2013.07.013_bb0295","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03256353","article-title":"Lucica GA-L glycated albumin assay kit. A new diagnostic test for diabetes mellitus","volume":"14","author":"Kohzuma","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.cca.2013.07.013_bb0300","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-8981(02)00207-3","article-title":"An enzymatic method for the measurement of glycated albumin in biological samples","volume":"324","author":"Kouzuma","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.07.013_bb0305","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1373\/clinchem.2005.053447","article-title":"Development of an automated enzymatic assay for the determination of glycated serum protein in human serum","volume":"51","author":"Wang","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0310","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1021\/pr700763r","article-title":"Proteomic profiling of nonenzymatically glycated proteins in human plasma and erythrocyte membranes","volume":"7","author":"Zhang","year":"2008","journal-title":"J Proteome Res"},{"key":"10.1016\/j.cca.2013.07.013_bb0315","doi-asserted-by":"crossref","first-page":"e32406","DOI":"10.1371\/journal.pone.0032406","article-title":"Raman spectroscopy provides a powerful diagnostic tool for accurate determination of albumin glycation","volume":"7","author":"Dingari","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2013.07.013_bb0320","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/lapl.200810007","article-title":"Monitoring of blood proteins glycation by refractive index and spectral measurements","volume":"5","author":"Zhernovaya","year":"2008","journal-title":"Laser Phys Lett"},{"key":"10.1016\/j.cca.2013.07.013_bb0325","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0531-5131(02)00953-6","article-title":"Analysis of glycated protein by capillary electrophoresis","volume":"1245","author":"Hinton","year":"2002","journal-title":"Int Congress Ser"},{"key":"10.1016\/j.cca.2013.07.013_bb0330","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/pmic.200900269","article-title":"Analysis of protein glycation using phenylboronate acrylamide gel electrophoresis","volume":"10","author":"Pereira Morais","year":"2010","journal-title":"Proteomics"},{"key":"10.1016\/j.cca.2013.07.013_bb0335","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1939-165X.2006.tb00136.x","article-title":"Separation of serum glycated proteins by agarose gel electrophoresis and nitroblue tetrazolium staining in diabetic and normal cats","volume":"35","author":"Martin","year":"2006","journal-title":"Vet Clin Pathol"},{"key":"10.1016\/j.cca.2013.07.013_bb0340","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1196\/annals.1333.014","article-title":"Dicarbonyl intermediates in the Maillard reaction","volume":"1043","author":"Thornalley","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2013.07.013_bb0345","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.abb.2005.10.019","article-title":"The effect of non-enzymatic glycation on the unfolding of human serum albumin","volume":"444","author":"Mendez","year":"2005","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.cca.2013.07.013_bb0350","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/bst0150267","article-title":"The effect of non-enzymatic glycation on ligand binding to human serum albumin","volume":"15","author":"Fitzpatrick","year":"1987","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.cca.2013.07.013_bb0355","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbagen.2003.08.001","article-title":"The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants","volume":"1623","author":"Nakajou","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2013.07.013_bb0360","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.jchromb.2010.08.021","article-title":"Chromatographic analysis of acetohexamide binding to glycated human serum albumin","volume":"878","author":"Joseph","year":"2010","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.cca.2013.07.013_bb0365","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jpba.2010.09.003","article-title":"Binding of tolbutamide to glycated human serum albumin","volume":"54","author":"Joseph","year":"2011","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cca.2013.07.013_bb0370","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jpba.2010.04.035","article-title":"The effects of glycation on the binding of human serum albumin to warfarin and l-tryptophan","volume":"53","author":"Joseph","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.cca.2013.07.013_bb0375","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00216-011-5382-8","article-title":"High-performance affinity chromatography and the analysis of drug interactions with modified proteins: binding of gliclazide with glycated human serum albumin","volume":"401","author":"Matsuda","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0380","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1016\/S0021-9258(18)32384-6","article-title":"The principal site of nonenzymatic glycosylation of human serum albumin in vivo","volume":"258","author":"Garlick","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0385","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0021-9258(17)37845-6","article-title":"Nonenzymatically glycosylated albumin","volume":"254","author":"Day","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0390","doi-asserted-by":"crossref","first-page":"13542","DOI":"10.1016\/S0021-9258(18)67052-8","article-title":"Nonenzymatic glycosylation of albumin in vivo: identification of multiple glycosylated sites","volume":"261","author":"Iberg","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0395","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.abb.2012.04.005","article-title":"Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus","volume":"522","author":"Arif","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.cca.2013.07.013_bb0400","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/bbrc.2001.4924","article-title":"Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin","volume":"284","author":"Zoellner","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2013.07.013_bb0405","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF01886793","article-title":"Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albumins","volume":"14","author":"Westwood","year":"1995","journal-title":"J Protein Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0410","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/092986607779117191","article-title":"Spectroscopic studies of the effects of glycation of human serum albumin on l-trp binding","volume":"14","author":"Barzegar","year":"2007","journal-title":"Prot Pep Lett"},{"key":"10.1016\/j.cca.2013.07.013_bb0415","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1248\/bpb.17.16","article-title":"Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism","volume":"17","author":"Okabe","year":"1994","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.cca.2013.07.013_bb0420","doi-asserted-by":"crossref","first-page":"22582","DOI":"10.1074\/jbc.M501480200","article-title":"NMR analysis of synthetic human serum albumin \u03b1-helix 28 identifies structural distortion upon Amadori modification","volume":"280","author":"Howard","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0425","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1093\/clinchem\/40.9.1766","article-title":"ELISA of pentosidine, an advanced glycation endproduct, in biological specimens","volume":"40","author":"Taneda","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0430","doi-asserted-by":"crossref","first-page":"25272","DOI":"10.1074\/jbc.273.39.25272","article-title":"Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation","volume":"273","author":"Lee","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0435","first-page":"81","article-title":"Specific quantitation by HPLC of protein (lysine) bound glucose in human serum albumin and other glycosylated proteins","volume":"19","author":"Schleicher","year":"1981","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1016\/j.cca.2013.07.013_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3640001","article-title":"Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate and application to N\u03b5-carboxymethyl\u2013lysine- and N\u03b5-(1-carboxyethyl)lysine-modified albumin","volume":"364","author":"Ahmed","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.cca.2013.07.013_bb0445","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj3640015","article-title":"Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence","volume":"364","author":"Ahmed","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.cca.2013.07.013_bb0450","series-title":"Handbook of affinity chromatography","author":"Lui","year":"2006"},{"key":"10.1016\/j.cca.2013.07.013_bb0455","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1021\/pr200040j","article-title":"Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects","volume":"10","author":"Zhang","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.cca.2013.07.013_bb0460","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1196\/annals.1433.060","article-title":"Analysis of Amadori peptides enriched by boronic acid affinity chromatography","volume":"1126","author":"Frolov","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2013.07.013_bb0465","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s00216-010-3810-9","article-title":"Identification and relative quantification of specific glycation sites in human serum albumin","volume":"397","author":"Frolov","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0470","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1021\/ac070619k","article-title":"Screening and sequencing of glycated proteins by neutral loss scan LC\/MS\/MS method","volume":"79","author":"Gadgil","year":"2007","journal-title":"Anal Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0475","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cca.2007.04.001","article-title":"Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin","volume":"382","author":"Kisugi","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.07.013_bb0480","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jasms.2003.11.014","article-title":"Enzymatic digestion and mass spectrometry in the studies of advanced glycation end products\/peptides","volume":"15","author":"Lapolla","year":"2004","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.cca.2013.07.013_bb0485","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1074\/mcp.M900439-MCP200","article-title":"Glycation isotopic labeling with 13C-reducing sugars for quantitative analysis of glycated proteins in human plasma","volume":"9","author":"Priego-Capote","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.cca.2013.07.013_bb0490","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ab.2010.11.034","article-title":"In vitro galactation of human serum albumin: analysis of the protein's galactation sites by mass spectrometry","volume":"410","author":"Frost","year":"2011","journal-title":"Anal Biochem"},{"key":"10.1016\/j.cca.2013.07.013_bb0495","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1196\/annals.1333.031","article-title":"Peptide mapping of human serum albumin modified by methylglyoxal in vitro and in vivo","volume":"1043","author":"Ahmed","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cca.2013.07.013_bb0500","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1074\/jbc.M410973200","article-title":"Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity","volume":"280","author":"Ahmed","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0505","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ab.2010.02.011","article-title":"Detection of glycation sites in proteins by high-resolution mass spectrometry combined with isotopic labeling","volume":"400","author":"Stefanowicz","year":"2010","journal-title":"Anal Biochem"},{"key":"10.1016\/j.cca.2013.07.013_bb0510","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/jms.1083","article-title":"Comprehensive analysis of glycated human serum albumin tryptic peptides by off-line liquid chromatography followed by MALDI analysis on a time-of-flight\/curved field reflectron tandem mass spectrometer","volume":"41","author":"Brancia","year":"2006","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.cca.2013.07.013_bb0515","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jms.431","article-title":"Accurate mass measurements by Fourier transform mass spectrometry in the study of advanced glycation end products\/peptides","volume":"38","author":"Marotta","year":"2003","journal-title":"J Mass Spectrom"},{"key":"10.1016\/j.cca.2013.07.013_bb0520","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1042\/bj2610871","article-title":"Identification of glycation at the N-terminus of albumin by gas chromatography\u2013mass spectrometry","volume":"261","author":"Robb","year":"1986","journal-title":"Biochem J"},{"key":"10.1016\/j.cca.2013.07.013_bb0525","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.cca.2010.04.007","article-title":"Quantitative analysis of glycation sites on human serum labeling using 16O\/18O labeling and matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"411","author":"Barnaby","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.07.013_bb0530","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cca.2010.10.018","article-title":"Comparison of modification sites formed on human serum albumin at various stages of glycation","volume":"412","author":"Barnaby","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.07.013_bb0535","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2007.06.011","article-title":"Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"385","author":"Wa","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.07.013_bb0540","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.cca.2011.05.012","article-title":"Quantitative analysis of glycation patterns in human serum albumin using 16O\/18O-labeling and MALDI\u2013TOF MS","volume":"412","author":"Barnaby","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.07.013_bb0545","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijms.2006.07.005","article-title":"Analyses of the in vitro non-enzymatic glycation of peptides\/proteins by matrix-assisted laser desorption\/ionization mass spectrometry","volume":"260","author":"Lee","year":"2007","journal-title":"Int J Mass Spectrom"},{"key":"10.1016\/j.cca.2013.07.013_bb0550","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1021\/ac303734c","article-title":"Development of affinity microcolumns for drug\u2013protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin","volume":"85","author":"Anguizola","year":"2013","journal-title":"Anal Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0555","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/j.1523-1755.2000.00398.x","article-title":"Mass spectrometric monitoring of albumin in uremia","volume":"58","author":"Thornalley","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.cca.2013.07.013_bb0560","first-page":"69","article-title":"3-Deoxyglucosone, an intermediate product of the Maillard reaction","volume":"304","author":"Kato","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.cca.2013.07.013_bb0565","first-page":"156","article-title":"Advanced glycation and retinal pathology during diabetes","volume":"57","author":"Stitt","year":"2005","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.cca.2013.07.013_bb0570","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/1567205043480582","article-title":"Involvement of advanced glycation end-products (AGEs) in Alzheimer's disease","volume":"1","author":"Takeuchi","year":"2004","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.cca.2013.07.013_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/rp.56.1.1","article-title":"Protein glycation, diabetes, and aging","volume":"56","author":"Ulrich","year":"2001","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.cca.2013.07.013_bb0580","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/DMDI.2008.23.1-2.125","article-title":"Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems \u2014 role in ageing and disease","volume":"23","author":"Thornalley","year":"2008","journal-title":"Drug Metabol Drug Interact"},{"key":"10.1016\/j.cca.2013.07.013_bb0585","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj20030763","article-title":"Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry","volume":"375","author":"Thornalley","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.cca.2013.07.013_bb0590","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end products: a review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2013.07.013_bb0595","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.biochi.2012.05.017","article-title":"Impaired drug-binding capacities of in vitro and in vivo glycated albumin","volume":"94","author":"Baraka-Vidot","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.cca.2013.07.013_bb0600","doi-asserted-by":"crossref","first-page":"46616","DOI":"10.1074\/jbc.M307155200","article-title":"Modification of proteins in vitro by physiological levels of glucose","volume":"278","author":"Voziyan","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0605","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-022X(94)90025-6","article-title":"Glycation of albumin: reaction with glucose, fructose, galactose, ribose or glyceraldehydes measured using four methods","volume":"28","author":"Syrovy","year":"1994","journal-title":"J Biochem Biophys Methods"},{"key":"10.1016\/j.cca.2013.07.013_bb0610","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jps.2600710223","article-title":"Glucosylated albumin and its influence on salicylate binding","volume":"1","author":"Mereish","year":"1982","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.cca.2013.07.013_bb0615","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00007691-198712000-00005","article-title":"Serum protein binding of phenytoin and valproic acid in insulin-dependent diabetes mellitus","volume":"9","author":"Gatti","year":"1987","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cca.2013.07.013_bb0620","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1015966402084","article-title":"The protein binding of phenytoin, propranolol, diazepam and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum","volume":"5","author":"McNamara","year":"1988","journal-title":"Pharm Res"},{"key":"10.1016\/j.cca.2013.07.013_bb0625","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/clpt.1984.241","article-title":"Abnormal serum protein binding of acidic drugs in diabetes mellitus","volume":"36","author":"Ruiz-Cabello","year":"1984","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cca.2013.07.013_bb0630","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1007\/s00216-013-6981-3","article-title":"Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin","volume":"405","author":"Jackson","year":"2013","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.cca.2013.07.013_bb0635","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jchromb.2010.04.019","article-title":"Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography","volume":"878","author":"Joseph","year":"2010","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.cca.2013.07.013_bb0640","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chroma.2012.09.091","article-title":"Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin","volume":"1265","author":"Matsuda","year":"2012","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.cca.2013.07.013_bb0645","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/0006-2952(84)90595-1","article-title":"Nonenzymatic glucosylation of human serum albumin and its influence on binding capacity of sulfonylurea drugs","volume":"33","author":"Tsuchiya","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cca.2013.07.013_bb0650","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1099-0801(199807\/08)12:4<203::AID-BMC736>3.0.CO;2-L","article-title":"Influence of glycosylation on the drug binding of human serum albumin","volume":"12","author":"Koizumi","year":"1998","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.cca.2013.07.013_bb0655","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF00315318","article-title":"Protein binding of digitoxin, valproate and phenytoin in sera from diabetics","volume":"45","author":"Doucet","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cca.2013.07.013_bb0660","first-page":"1829","article-title":"Effects of nonenzymatic glycosylation and fatty acids on tryptophan binding to human serum albumin","volume":"43","author":"Bohney","year":"1992"},{"key":"10.1016\/j.cca.2013.07.013_bb0665","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1016\/j.chroma.2008.09.080","article-title":"Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography","volume":"1216","author":"Joseph","year":"2009","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.cca.2013.07.013_bb0670","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jssc.200800567","article-title":"Evaluation of indole-based probes for high-throughput screening of drug binding to human serum albumin: analysis by high-performance affinity chromatography","volume":"32","author":"Conrad","year":"2009","journal-title":"J Sep Sci"},{"key":"10.1016\/j.cca.2013.07.013_bb0675","series-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Davis","year":"2006"},{"key":"10.1016\/j.cca.2013.07.013_bb0680","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-2007-978938","article-title":"Lipolytic response during spontaneous hypoglycaemia in insulin-dependent diabetic subjects","volume":"30","author":"Hagstrom-Toft","year":"1998","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cca.2013.07.013_bb0685","first-page":"1113","article-title":"Juvenile diabetes mellitus and serum lipids and lipoprotein levels","volume":"130","author":"Chase","year":"1976","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.cca.2013.07.013_bb0690","first-page":"277","article-title":"Effects of free fatty acids on the course of gestational diabetes mellitus","volume":"27","author":"Bomba-Opon","year":"2006","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.cca.2013.07.013_bb0695","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-2275(20)36723-7","article-title":"Fatty acid binding to plasma albumin","volume":"16","author":"Spector","year":"1975","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.07.013_bb0700","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0378-4347(92)80252-L","article-title":"Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase","volume":"577","author":"Noctor","year":"1992","journal-title":"J Chromatogr"},{"key":"10.1016\/j.cca.2013.07.013_bb0705","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1006\/jmbi.2000.4158","article-title":"Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin","volume":"303","author":"Bhattacharya","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1016\/j.cca.2013.07.013_bb0710","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1006\/jmbi.2000.5208","article-title":"Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids","volume":"314","author":"Petitpas","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1016\/j.cca.2013.07.013_bb0715","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1021\/bi00080a032","article-title":"Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB","volume":"32","author":"Richieri","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.cca.2013.07.013_bb0720","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.jchromb.2010.09.033","article-title":"Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids","volume":"878","author":"Basiaga","year":"2010","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.cca.2013.07.013_bb0725","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00002018-200022040-00004","article-title":"Comparative tolerability of sulphonylureas in diabetes mellitus","volume":"22","author":"Harrower","year":"2000","journal-title":"Drug Saf"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113002817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113002817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T19:12:04Z","timestamp":1646161924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898113002817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":145,"alternative-id":["S0009898113002817"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.07.013","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review: Glycation of human serum albumin","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}